Défaillance rénale

  • F. Antonini
  • F. Garnier
  • C. Martin
Part of the Le point sur⋯ book series (POINT)


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Riedemann NC, Guo RF, Ward PA (2003) The enigma of sepsis. J Clin Invest 112: 460–7CrossRefPubMedGoogle Scholar
  2. 2.
    Rangel-Frausto MS, Pittet D, Costigan M et al. (1995) The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 273: 117–23CrossRefPubMedGoogle Scholar
  3. 3.
    Angus DC, Linde-Zwirble WT, Lidicker J et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303–10PubMedGoogle Scholar
  4. 4.
    Edelstein CL, Schrier RW (2001) Pathophysiology of ischemic acute renal failure. In: Schrier RW, ed. Diseases of the kidney and urinary tract. 7th ed., vol. 2. Philadelphia: Lippincott Williams & Wilkins, 1041–69Google Scholar
  5. 5.
    Robert W, Schrier MD, Wei Wang MD (2004) Acute renal failure and sepsis. N Engl J Med 351: 159–69Google Scholar
  6. 6.
    Landry DW, Oliver JA (2001) The pathogenesis of vasodilatory shock. N Engl J Med 345: 588–95CrossRefPubMedGoogle Scholar
  7. 7.
    Esson ML, Schrier RW (2002) Diagnosis and treatment of acute tubular necrosis. Ann Intern Med 137: 744–52PubMedGoogle Scholar
  8. 8.
    Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ (1996) Acute renal failure in intensive care units-causes, outcome, and prognostic factors of hospital mortality: a prospective, multicenter study. Crit Care Med 24: 192–8CrossRefPubMedGoogle Scholar
  9. 9.
    Schrier RW (1990) Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Intern Med 113: 155–9PubMedGoogle Scholar
  10. 10.
    Schrier RW, Abraham WT (1999) Hormones and hemodynamics in heart failure. N Engl J Med 341: 577–85CrossRefPubMedGoogle Scholar
  11. 11.
    Benedict CR, Rose JA (1992) Arterial norepinephrine changes in patients with septic shock. Circ Shock 38: 165–72PubMedGoogle Scholar
  12. 12.
    Cumming AD, Driedger AA, McDonald JW et al. (1988) Vasoactive hormones in the renal response to systemic sepsis. Am J Kidney Dis 11: 23–32PubMedGoogle Scholar
  13. 13.
    Thiemermann C, Szabo C, Mitchell JA, Vane JR (1993) Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci U S A 90: 267–71PubMedGoogle Scholar
  14. 14.
    Titheradge MA (1999). Nitric oxide in septic shock. Biochim Biophys Acta 1411: 437–55PubMedGoogle Scholar
  15. 15.
    Hollenberg SM, Broussard M, Osman J, Parrillo JE (2000) Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circ Res 86: 774–8PubMedGoogle Scholar
  16. 16.
    Hollenberg SM, Cunnion RE, Zimmerberg J (1993) Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol 264: H660–3PubMedGoogle Scholar
  17. 17.
    Davies NW (1990) Modulation of ATP-sensitive K+ channels in skeletal muscle by intracellular protons. Nature 343: 375–7CrossRefPubMedGoogle Scholar
  18. 18.
    Keung EC, Li Q (1991) Lactate activates ATP-sensitive potassium channels in guinea pig ventricular myocytes. J Clin Invest 88: 1772–7PubMedGoogle Scholar
  19. 19.
    Morales D, Madigan J, Cullinane S et al. (1999) Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 100: 226–9PubMedGoogle Scholar
  20. 20.
    Landry DW, Levin HR, Gallant EM et al. (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95: 1122–5PubMedGoogle Scholar
  21. 21.
    Wakatsuki T, Nakaya Y, Inoue I (1992) Vasopressin modulates K(+)-channel activities of cultured smooth muscle cells from porcine coronary artery. Am J Physiol 263: H491–6PubMedGoogle Scholar
  22. 22.
    Umino T, Kusano E, Muto S et al. (1999) AVP inhibits LPS-and IL-1beta-stimulated NO and cGMP via V1 receptor in cultured rat mesangial cells. Am J Physiol 276: F433–41PubMedGoogle Scholar
  23. 23.
    Zerbe RL, Henry DP, Robertson GL (1983) Vasopressin response to orthostatic hypotension: etiologic and clinical implications. Am J Med 74: 265–71CrossRefPubMedGoogle Scholar
  24. 24.
    Kaufmann H, Oribe E, Oliver JA (1991) Plasma endothelin during upright tilt: relevance for orthostatic hypotension? Lancet 338: 1542–5 (1977) The effects of hypotension and hypovolaemia on the liberation of vasopressin during haemorrhage in the unanaesthetized monkey (Macaca mulatta). Pflugers Arch 371: 193-200CrossRefPubMedGoogle Scholar
  25. 25.
    Arnauld E, Czernichow P, Fumoux F, Vincent JD (1977), The effects of hypotension and hypovolaemia on the liberation of vasopressin during haemorrhage in the unaenesthetized monkey (Macaca mulatta). Pfugers Arch 371: 193–200Google Scholar
  26. 26.
    Bartelstone HJ, Nasmyth PA (1965) Vasopressin potentiation of catecholamine actions in dog, rat, cat, and rat aortic strip. Am J Physiol 208: 754–62PubMedGoogle Scholar
  27. 27.
    Cowley AW Jr, Liard JF (1988) Vasopressin and arterial pressure regulation: special lecture. Hypertension 11: I–25Google Scholar
  28. 28.
    Schrier RW, Abraham E (1995) Aggressive volume expansion and pseudo-ARDS. Hosp Pract (Off Ed) 30: 19, 23-19, 23Google Scholar
  29. 29.
    Sanz E, Lopez Novoa JM, Linares M et al. (1990) Intravascular and interstitial fluid dynamics in rats treated with minoxidil. J Cardiovasc Pharmacol 15: 485–92PubMedGoogle Scholar
  30. 30.
    Neveu H, Kleinknecht D, Brivet F et al. (1996) Prognostic factors in acute renal failure due to sepsis: results of a prospective multicentre study. Nephrol Dial Transplant 11: 293–9PubMedGoogle Scholar
  31. 31.
    Kikeri D, Pennell JP, Hwang KH et al. (1986) Endotoxemic acute renal failure in awake rats. Am J Physiol 250: F1098–F1106PubMedGoogle Scholar
  32. 32.
    Wang W, Falk SA, Jittikanont S et al. (2002) Protective effect of renal denervation on normotensive endotoxemia-induced acute renal failure in mice. Am J Physiol Renal Physiol 283: F583–7PubMedGoogle Scholar
  33. 33.
    Hohlfeld T, Klemm P, Thiemermann C, Warner TD, Schror K, Vane JR (1995) The contribution of tumour necrosis factor-alpha and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin. Br J Pharmacol 116: 3309–15PubMedGoogle Scholar
  34. 34.
    Kon V, Badr KF (1991) Biological actions and pathophysiologic significance of endothelin in the kidney. Kidney Int 40: 1–12PubMedGoogle Scholar
  35. 35.
    Filep JG (2000) Role for endogenous endothelin in the regulation of plasma volume and albumin escape during endotoxin shock in conscious rats. Br J Pharmacol 129: 975–83CrossRefPubMedGoogle Scholar
  36. 36.
    Schwartz D, Mendonca M, Schwartz I et al. (1997) Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest 100: 439–48PubMedGoogle Scholar
  37. 37.
    Knotek M, Rogachev B, Wang W et al. (2001) Endotoxemic renal failure in mice: role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int 59: 2243–9PubMedGoogle Scholar
  38. 38.
    Reinhart K, Bayer O, Brunkhorst F, Meisner M (2002) Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med 30: Suppl. S302–12PubMedGoogle Scholar
  39. 39.
    Wang W, Mitra A, Poole BD et al. (2001) Endothelial nitric oxide synthase (eNOS) deficient mice exhibit increased susceptibility to endotoxin-induced acute renal failure (ARF). J Am Soc Nephrol.Google Scholar
  40. 40.
    Gallagher J, Fisher C, Sherman B et al. (2001) A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-alpha antibody afelimomab in patients with sepsis syndrome. Intensive Care Med 27: 1169–78CrossRefPubMedGoogle Scholar
  41. 41.
    Reinhart K, Karzai W (2001) Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit Care Med 29. Suppl. S121–5PubMedGoogle Scholar
  42. 42.
    Wang W, Jittikanont S, Falk SA et al. (2003) Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemia-related acute renal failure. Am J Physiol Renal Physiol 284: F532–7PubMedGoogle Scholar
  43. 43.
    Lopez A, Lorente JA, Steingrub J et al. (2004) Multiple-center, randomized, placebocontrolled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32: 21–30PubMedGoogle Scholar
  44. 44.
    Melnikov VY, Ecder T, Fantuzzi G et al. (2001) Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest 107: 1145–52PubMedGoogle Scholar
  45. 45.
    Wang W, Reznikof L, Falk SA et al. (2003) Caspase-1 knockout mice are resistant to endotoxemic acute renal failure (ARF). J Am Soc Nephrol 14: 350AGoogle Scholar
  46. 46.
    Schor N (2002) Acute renal failure and the sepsis syndrome. Kidney Int 61: 764–76CrossRefPubMedGoogle Scholar
  47. 47.
    Ulloa L, Ochani M, Yang H et al. (2002) Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA 99: 12351–6CrossRefPubMedGoogle Scholar
  48. 48.
    Riedemann NC, Guo RF, Neff TA et al. (2002) Increased C5a receptor expression in sepsis. J Clin Invest 110: 101–8CrossRefPubMedGoogle Scholar
  49. 49.
    Huber-Lang MS, Riedeman NC, Sarma JV et al. (2002) Protection of innate immunity by C5aR antagonist in septic mice. FASEB J 16: 1567–74CrossRefPubMedGoogle Scholar
  50. 50.
    Czermak BJ, Sarma V, Pierson CL et al. (1999) Protective effects of C5a blockade in sepsis. Nat Med 5: 788–92PubMedGoogle Scholar
  51. 51.
    Remick DG, Newcomb DE, Bolgos GL, Call DR (2000) Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13: 110–6PubMedGoogle Scholar
  52. 52.
    Fink MP, Heard SO (1990) Laboratory models of sepsis and septic shock. J Surg Res 49: 186–96CrossRefPubMedGoogle Scholar
  53. 53.
    Rivers E, Nguyen B, Havstad S et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368–77CrossRefPubMedGoogle Scholar
  54. 54.
    Hayes MA, Timmins AC, Yau EHS et al. (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330: 1717–22CrossRefPubMedGoogle Scholar
  55. 55.
    Connors AF Jr, Speroff T, Dawson NV et al. (1996) The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 276: 889–97CrossRefPubMedGoogle Scholar
  56. 56.
    Opal SM, Cross AS (1999) Clinical trials for severe sepsis: past failures, and future hopes. Infect Dis Clin North Am 13: 285–97CrossRefPubMedGoogle Scholar
  57. 57.
    Van den Berghe G, Wouters P, Weekers F et al. (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345: 1359–67PubMedGoogle Scholar
  58. 58.
    Finney SJ, Zekveld C, Elia A, Evans TW (2003) Glucose control and mortality in critically ill patients. JAMA 290: 2041–7CrossRefPubMedGoogle Scholar
  59. 59.
    Cronin L, Cook DJ, Carlet J et al. (1995) Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 23: 1430–9PubMedGoogle Scholar
  60. 60.
    Lefering R, Neugebauer EA (1995) Steroid controversy in sepsis and septic shock: a metaanalysis. Crit Care Med 23: 1294–1303PubMedGoogle Scholar
  61. 61.
    Annane D, Sebille V, Charpentier C et al. (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288: 862–71CrossRefPubMedGoogle Scholar
  62. 62.
    Kress JP, Pohlman AS, O’Connor MF, Hall JB (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342: 1471–7CrossRefPubMedGoogle Scholar
  63. 63.
    Schrier RW, Henderson HS, Tisher CC, Tannen RL (1967) Nephropathy associated with heat stress and exercise. Ann Intern Med 67: 356–76PubMedGoogle Scholar
  64. 64.
    Phu NH, Hien TT, Mai NTH et al. (2002)Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med 347: 895–902CrossRefPubMedGoogle Scholar
  65. 65.
    Schiffl H, Lang SM, Fischer R (2002) Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346: 305–10CrossRefPubMedGoogle Scholar
  66. 66.
    Tonelli M, Manns B, Feller-Kopman D (2002) Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 40: 875–85CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag France 2005

Authors and Affiliations

  • F. Antonini
  • F. Garnier
  • C. Martin

There are no affiliations available

Personalised recommendations